首页> 外国专利> 1,4-DISUBSTITUTED BENZOFUSED CYCLOALKYL UREA COMPOUNDS USEFUL IN TREATING CYTOKINE MEDIATED DISEASES

1,4-DISUBSTITUTED BENZOFUSED CYCLOALKYL UREA COMPOUNDS USEFUL IN TREATING CYTOKINE MEDIATED DISEASES

机译:1,4-二取代的苯并用环烷基尿素化合物可用于治疗细胞因子介导的疾病

摘要

Disclosed are 1,4-disubstituted benzo-fused urea compounds of formula (I)(see formula II)wherein ring A is an optionally substituted fused saturated or unsaturatedringcontaining 3-5 carbon atoms, Ar is an optionally substituted heterocyclicgroup, Lis a linking group and Q is a substituted phenyl, pyridine, pyrimidine, etc.Thecompounds inhibit production of cytokines involved in inflammatory processesandare thus useful for treating diseases and pathological conditions involvinginflammation such as chronic inflammatory disease. Also disclosed areprocessesfor preparing these compounds and compositions, and pharmaceuticalcompositions comprising these compounds.
机译:公开了式(I)的1,4-二取代的苯并稠合的脲化合物(参见公式II)其中环A是任选取代的稠合的饱和或不饱和的环含有3-5个碳原子,Ar是一个可选取代的杂环L组是一个连接基团,Q是一个取代的苯基,吡啶,嘧啶等。的化合物抑制炎症过程中涉及的细胞因子的产生和因此可用于治疗涉及以下疾病的疾病和病理状况炎症,例如慢性炎症。还公开了流程用于制备这些化合物和组合物以及药物包含这些化合物的组合物。

著录项

  • 公开/公告号CA2473634C

    专利类型

  • 公开/公告日2011-11-29

    原文格式PDF

  • 申请/专利权人 BOEHRINGER INGELHEIM PHARMACEUTICALS INC.;

    申请/专利号CA20032473634

  • 申请日2003-02-19

  • 分类号C07D403/12;A61K31/454;A61K31/501;A61K31/5377;A61P29;C07D231/40;C07D401/12;C07D401/14;C07D403/14;C07D405/14;C07D409/14;C07D413/12;C07D413/14;C07D417/14;C07D419/14;C07D491/08;

  • 国家 CA

  • 入库时间 2022-08-21 17:20:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号